Mitsui Chemicals 경영진
경영진 기준 점검 0/4
Mitsui Chemicals CEO는 Satoshi Ichimura, Apr2026 에 임명되었습니다 의 임기는 1년 미만입니다. 는 ¥15.88M 가치에 해당하는 회사 주식의 0.002% 직접 소유합니다. 경영진과 이사회의 평균 재임 기간은 각각 1.7 년과 2.3 년입니다.
핵심 정보
Satoshi Ichimura
최고경영자
n/a
총 보수
| CEO 급여 비율 | n/a |
| CEO 재임 기간 | less than a year |
| CEO 지분 보유율 | 0.002% |
| 경영진 평균 재임 기간 | 1.7yrs |
| 이사회 평균 재임 기간 | 2.3yrs |
최근 경영진 업데이트
Recent updates
내러티브 업데이트 • Sep 07
4183: Earnings Guidance And Capital Moves Will Shape A Balanced Outlook
Mitsui Chemicals' analyst price target has shifted from ¥2,350 to about ¥2,435. Analysts point to updated assumptions on fair value, discount rate, profit margins and future P/E as the main drivers of the change.분석 기사 • Aug 07
Analyst Estimates: Here's What Brokers Think Of Mitsui Chemicals, Inc. (TSE:4183) After Its First-Quarter Report
It's been a good week for Mitsui Chemicals, Inc. ( TSE:4183 ) shareholders, because the company has just released its...
내러티브 업데이트 • Jul 30
4183: Treasury Share Disposal Will Support Long Term Upside As Earnings Multiple Re-Rates
Analysts have raised their price target for Mitsui Chemicals from ¥3,000 to about ¥3,355, explaining the change with updated assumptions for revenue growth, profit margins, and future P/E levels. What's in the News Mitsui Chemicals has scheduled a board meeting for Jun 24, 2026 to consider and approve the disposal of treasury shares, along with other business-related matters.
내러티브 업데이트 • Jul 15
4183: U.S. Oral Care Hub And Richer Multiple Will Limit Future Returns
Analysts have revised their 12 month price target for Mitsui Chemicals from ¥1,550 to ¥1,790, citing updated assumptions for slightly higher revenue growth, improved profit margins, and a modest increase in the future P/E multiple. What’s in the News for Mitsui Chemicals Mitsui Chemicals is shifting its global oral care headquarters to the U.S., aiming to make oral care a core growth pillar and position itself more as a solutions provider for dental patients and professionals.내러티브 업데이트 • Jul 01
4183: Buybacks And Treasury Share Disposal Plans Will Shape A Balanced Outlook
The analyst price target for Mitsui Chemicals has been revised from ¥2,251.67 to ¥2,350.00. Analysts cited updated assumptions around revenue growth, profit margin and future P/E as the basis for the change.내러티브 업데이트 • Jun 17
4183: Softer Margins And Oral Care Expansion Will Restrain Future Share Returns
Analysts have maintained their fair value estimate for Mitsui Chemicals at ¥1,550, while adjusting key assumptions including a lower discount rate, slightly softer revenue growth and profit margin expectations, and a higher future P/E multiple to reflect the current research backdrop. What’s in the News for Mitsui Chemicals Mitsui Chemicals’ U.S. subsidiary agreed to acquire Ultradent Products to expand the group’s global oral care business, combining Ultradent’s U.S. presence with Mitsui’s Kulzer operations in the EMEA region.내러티브 업데이트 • Jun 03
4183: Share Buybacks Will Support Long Term Upside As Earnings Multiple Re-Rates
Analysts are keeping their ¥3,000 price target for Mitsui Chemicals unchanged. They point to small model tweaks in the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a shift in the overall outlook.내러티브 업데이트 • May 15
4183: Share Buybacks Will Support Long Term Upside As Earnings Multiple Re-Rates
Analysts have kept their fair value estimate for Mitsui Chemicals steady at ¥3,000 per share. The updated price target reflects slightly adjusted assumptions for discount rate, revenue growth, profit margin and future P/E rather than a major shift in their overall view of the stock.내러티브 업데이트 • Apr 26
4183: Weaker Earnings Outlook And Margin Pressure Will Weigh On Future Returns
Analysts have raised Mitsui Chemicals' fair value estimate from ¥1,500 to ¥1,550, citing updated assumptions that combine a slightly higher discount rate and a modestly lower profit margin with a materially higher revenue growth outlook and a marginally lower future P/E multiple. What's in the News Mitsui Chemicals has launched a share repurchase program of up to 18,400,000 shares, or 4.89% of its share capital, for ¥30,000m, with plans to cancel treasury shares after repurchase and a program period running until July 31, 2026 (Key Developments).내러티브 업데이트 • Apr 12
4183: Share Buybacks Will Support Long Term Upside Despite Near Term Margin Pressure
Analysts have kept the fair value estimate for Mitsui Chemicals steady at ¥3,000 by refining assumptions on discount rate, revenue growth, profit margin, and future P/E, which together underpin the updated price target narrative. What's in the News Mitsui Chemicals has launched a share repurchase program to buy up to 18,400,000 shares, around 4.89% of its share capital, for ¥30,000m, with plans to cancel the repurchased shares and run the program through July 31, 2026 (Board meeting and buyback transaction announcements, February 5, 2026).내러티브 업데이트 • Mar 28
4183: Renewable Plastics And Buybacks Will Support Long Term Share Upside
Analysts have maintained their ¥3,000 price target for Mitsui Chemicals, noting that only minor adjustments to assumptions such as discount rate, revenue growth, profit margin, and future P/E have been made, and these do not materially change their overall view of the shares. What's in the News Mitsui Chemicals is part of a 14 company global supply chain across five countries and regions to produce renewable plastics for Sony's high performance audio visual products, with a focus on tracking and documenting GHG emissions across the chain and supporting Sony's move away from virgin fossil based plastics (Key Developments).내러티브 업데이트 • Mar 14
4183: Renewable Plastics Supply Chain Will Reshape Long-Term Earnings Profile
Analysts have reset their price target on Mitsui Chemicals from ¥5,400 to ¥3,000, reflecting updated assumptions for slightly lower discount rates, as well as revised expectations for revenue growth, profit margins, and future P/E levels. What's in the News Mitsui Chemicals joined thirteen other companies across five countries to build what is described as the world's first global supply chain for renewable plastics for use in Sony's high performance audio visual products, allowing tracking of greenhouse gas emissions across the chain and supporting Sony's goal to reduce virgin fossil based plastics (Key Developments).분석 기사 • Feb 13
Mitsui Chemicals' (TSE:4183) Conservative Accounting Might Explain Soft Earnings
Shareholders appeared unconcerned with Mitsui Chemicals, Inc.'s ( TSE:4183 ) lackluster earnings report last week. Our...분석 기사 • Feb 08
Earnings Miss: Mitsui Chemicals, Inc. Missed EPS By 63% And Analysts Are Revising Their Forecasts
As you might know, Mitsui Chemicals, Inc. ( TSE:4183 ) last week released its latest quarterly, and things did not turn...분석 기사 • Feb 05
Why Investors Shouldn't Be Surprised By Mitsui Chemicals, Inc.'s (TSE:4183) P/E
With a price-to-earnings (or "P/E") ratio of 47.9x Mitsui Chemicals, Inc. ( TSE:4183 ) may be sending very bearish...내러티브 업데이트 • Feb 05
4183: Decarbonization Investments And Stock Split Plans Will Shape A Balanced Outlook
Analysts have lifted their fair value estimate for Mitsui Chemicals from ¥2,170.83 to ¥2,251.67, citing slightly lower discount rate assumptions, minor adjustments to long term revenue growth and profit margin forecasts, and a modestly higher future P/E multiple. What's in the News Mitsui Chemicals, Asahi Kasei, and Mitsubishi Chemical were selected for Japan's Fiscal 2025 HtA Support Program to support decarbonization and production conversion at two ethylene facilities in western Japan, with a stated investment scale of ¥21.2b and a maximum subsidy application amount of ¥10.4b (HtA Support Program announcement).내러티브 업데이트 • Jan 22
4183: Stock Split Plans And Updated Guidance Will Shape A Balanced Outlook
Analysts have revised their price target on Mitsui Chemicals from ¥4,250.91 to ¥2,170.83, citing updated assumptions around slightly lower discount rates, adjusted revenue growth and profit margin expectations, and a modestly different future P/E multiple. What's in the News Mitsui Chemicals has scheduled a board meeting for November 11, 2025, with an agenda that includes discussing a potential stock split (Key Developments).내러티브 업데이트 • Jan 07
4183: Future Stock Split And Margin Pressure Will Weigh On Returns
Analysts have adjusted their price target for Mitsui Chemicals from ¥3,000 to ¥1,500, citing updated assumptions for revenue growth, profit margins, and future P/E multiples. What's in the News Mitsui Chemicals scheduled a board meeting for November 11, 2025 to discuss a potential stock split (Key Developments).분석 기사 • Dec 03
Mitsui Chemicals (TSE:4183) Has Announced A Dividend Of ¥75.00
Mitsui Chemicals, Inc. ( TSE:4183 ) will pay a dividend of ¥75.00 on the 25th of June. The dividend yield will be 3.9...분석 기사 • Oct 23
Investors Appear Satisfied With Mitsui Chemicals, Inc.'s (TSE:4183) Prospects
When close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 14x, you may consider Mitsui...분석 기사 • Sep 22
Mitsui Chemicals' (TSE:4183) Dividend Will Be ¥75.00
Mitsui Chemicals, Inc. ( TSE:4183 ) has announced that it will pay a dividend of ¥75.00 per share on the 3rd of...내러티브 업데이트 • Sep 21
Specialty Chemicals Restructuring Will Unlock Sustainable Market Potential
The upward revision in Mitsui Chemicals’ price target is underpinned by a marginal improvement in consensus revenue growth forecasts and a slightly higher expected future P/E, resulting in the fair value estimate increasing from ¥4151 to ¥4251. What's in the News Revised H1 2025 earnings guidance: sales revenue JPY 818.0 billion, operating income JPY 31.0 billion, net income JPY 7.5 billion, basic EPS JPY 40.03.내러티브 업데이트 • Sep 06
Specialty Chemicals Restructuring Will Unlock Sustainable Market Potential
With Mitsui Chemicals’ consensus analyst price target and key valuation metrics such as the discount rate and future P/E ratio all remaining effectively unchanged, analysts see no material change in fair value, maintaining the target at ¥4151. What's in the News Revised first-half FY2025 guidance: sales revenue expected at JPY 818.0 billion, operating income JPY 31.0 billion, net income JPY 7.5 billion, and basic EPS JPY 40.03.
새로운 내러티브 • Jan 05
Yen Depreciation And Specialty Chemicals Surge Will Propel Operating Income And Revenue Growth
Yen depreciation and improved trade terms are expected to boost operating income in specialty chemicals, positively impacting revenue.CEO
Satoshi Ichimura (59 yo)
less than a year
재임 기간
Mr. Satoshi Ichimura is President, CEO and Representative Director of Mitsui Chemicals, Inc since April 1, 2026. He was Managing Executive Officer and CSO at Mitsui Chemicals, Inc since April 2024 until Ap...
리더십 팀
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| CEO, President & Representative Director | less than a year | 데이터 없음 | 0.0021% ¥ 15.9m | |
| Managing Executive Officer | 1.7yrs | 데이터 없음 | 데이터 없음 | |
| Managing Executive Officer CTO & Director | 1.7yrs | 데이터 없음 | 데이터 없음 | |
| Director of IR Department - Corporate Communicate Division | no data | 데이터 없음 | 데이터 없음 | |
| CHRO & Managing Executive Officer | less than a year | 데이터 없음 | 데이터 없음 | |
| Senior Managing Executive Officer & Representative Director | no data | 데이터 없음 | 0.012% ¥ 94.3m | |
| Executive Officer & Senior VP of Digital Transformation Sector | 2.7yrs | 데이터 없음 | 데이터 없음 | |
| Senior Managing Executive Officer & President of Basic & Green Materials Business Sector | 4.7yrs | 데이터 없음 | 데이터 없음 | |
| Managing Executive Officer | 4.7yrs | 데이터 없음 | 데이터 없음 | |
| Managing Executive Officer | 1.7yrs | 데이터 없음 | 데이터 없음 | |
| Managing Executive Officer & President of Life & Healthcare Solutions Business Sector | 1.7yrs | 데이터 없음 | 데이터 없음 | |
| Managing Executive Officer & President of ICT Solutions Business Sector | less than a year | 데이터 없음 | 데이터 없음 |
1.7yrs
평균 재임 기간
62.5yo
평균 나이
경험이 풍부한 관리: 4183의 경영진은 경험이 부족한 것으로 간주됩니다(평균 재임 1.7 년) — 신규 팀일 수 있습니다.
이사회 구성원
| 이름 | 직위 | 재임 기간 | 보수 | 지분 |
|---|---|---|---|---|
| CEO, President & Representative Director | 1.3yrs | 데이터 없음 | 0.0021% ¥ 15.9m | |
| Managing Executive Officer | no data | 데이터 없음 | 데이터 없음 | |
| Managing Executive Officer CTO & Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Senior Managing Executive Officer & Representative Director | 1.3yrs | 데이터 없음 | 0.012% ¥ 94.3m | |
| Director | less than a year | 데이터 없음 | 데이터 없음 | |
| Chairman | 8.3yrs | JP¥138.00m | 0.028% ¥ 215.1m | |
| Audit & Supervisory Board Member | 3.3yrs | 데이터 없음 | 데이터 없음 | |
| Audit & Supervisory Board Member | 2.3yrs | 데이터 없음 | 0.010% ¥ 79.7m | |
| Independent Outside Director | 5.3yrs | 데이터 없음 | 0.0016% ¥ 12.4m | |
| Independent Outside Director | 4.3yrs | 데이터 없음 | 0.0010% ¥ 7.7m | |
| Independent Outside Director | 2.3yrs | 데이터 없음 | 데이터 없음 | |
| Audit & Supervisory Board Member | 3.3yrs | 데이터 없음 | 데이터 없음 |
2.3yrs
평균 재임 기간
65yo
평균 나이
경험이 풍부한 이사회: 4183의 이사회는 경험이 부족한 것으로 간주됩니다(평균 재임 2.3 년) — 신규 이사회일 가능성이 있습니다.
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/09/10 19:23 |
| 종가 | 2026/09/10 00:00 |
| 수익 | 2026/06/30 |
| 연간 수익 | 2026/03/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델의 세부 정보는 당사의 GitHub 페이지에서 확인하실 수 있습니다. 또한 보고서 사용 방법에 대한 가이드와 YouTube 튜토리얼도 제공하고 있습니다.
Simply Wall St 분석 모델을 설계하고 구축한 에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
Mitsui Chemicals, Inc.는 19명의 분석가가 다루고 있습니다. 이 중 11명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Mikiya Yamada | Barclays |
| Takashi Enomoto | BofA Global Research |
| Yuta Nishiyama | Citigroup Inc |